Methylprednisolone treatment in multiple sclerosis: effect of treatment, pharmacokinetics, future.

about

Management of Multiple Sclerosis in the Breastfeeding Mother

P2860

Q26766337-D86B3FF9-6E08-45AA-97DD-EB7E7E6234AD

P2860

Methylprednisolone treatment in multiple sclerosis: effect of treatment, pharmacokinetics, future.

Item

http://www.wikidata.org/entity/Q40934010

description

1996 nî lūn-bûn

@nan

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

1996年论文

@zh

1996年论文

@zh-cn

name

Methylprednisolone treatment i ...... ent, pharmacokinetics, future.

@en

type

Item

label

Methylprednisolone treatment i ...... ent, pharmacokinetics, future.

@en

prefLabel

Methylprednisolone treatment i ...... ent, pharmacokinetics, future.

@en

P1476

Methylprednisolone treatment i ...... ent, pharmacokinetics, future.

@en

P2093

F Barkhof

http://www.w3.org/2001/XMLSchema#string

O R Hommes

http://www.w3.org/2001/XMLSchema#string

P J Jongen

http://www.w3.org/2001/XMLSchema#string

S T Frequin

http://www.w3.org/2001/XMLSchema#string

P2860

The effects of high-dose methylprednisolone on gadolinium-enhanced magnetic resonance imaging and cerebrospinal fluid measurements in multiple sclerosis.

Quantitative magnetic resonance imaging in multiple sclerosis: the effect of high dose intravenous methylprednisolone.

High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect

The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group.

A correlative triad of gadolinium-DTPA MRI, EDSS, and CSF-MBP in relapsing multiple sclerosis patients treated with high-dose intravenous methylprednisolone.

Limited duration of the effect of methylprednisolone on changes on MRI in multiple sclerosis.

Megadose corticosteroids in multiple sclerosis.

The effect of high-dose steroids on MRI gadolinium enhancement in acute demyelinating lesions.

Quantitative MRI changes in gadolinium-DTPA enhancement after high-dose intravenous methylprednisolone in multiple sclerosis.

P304

327-328

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/135245859600100607

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1996-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9345410

http://www.w3.org/2001/XMLSchema#string

Methylprednisolone treatment in multiple sclerosis: effect of treatment, pharmacokinetics, future.

about

P2860

P2860

Methylprednisolone treatment in multiple sclerosis: effect of treatment, pharmacokinetics, future.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698